FDA drug center head expected to leave after commissioner's exit, sources say

FDA leadership shake-up continues with departure of top drug regulator

Dr. Tracy Beth Høeg is leaving her role as head of the FDA division that regulates over-the-counter and prescription drugs, according to a Department of Health and Human Services official

Acting FDA Commissioner Promises Faster Safety Review of Dangerous Abortion Pill

The acting commissioner of the Food and Drug Administration has promised to prioritize a safety review of the abortion pill after his predecessor was accused of delaying it, pro-life leaders say. Kyle Diamantas, FDA deputy commissioner for food, is serving as acting FDA commissioner in the wake of Dr. Marty Makary’s departure. Though the Trump administration is reportedly soon picking a permanent commissioner to lead the agency, Diamantas promis…

FDA drug center head Tracy Beth Høeg leaves as agency faces leadership vacuum

Acting drug center director made controversial decisions on vaccines and drug reviews, leaves just days after FDA Commissioner Marty Makary resigned.

FDA drug center head expected to leave after commissioner’s exit, sources say

Exclusive-FDA drug center head expected to leave after commissioner’s exit, sources say

FDA leadership fallout continues as acting CDER Director Hoeg expected to depart

FDA leadership shifts: Acting CDER chief Tracey Beth Hoeg may step down after Makary’s exit. Read more here.

Acting FDA Commissioner Promises Action on Abortion Pill

Kyle Diamantas, FDA deputy commissioner for food, is serving as acting FDA commissioner in the wake of Dr. Marty Makary’s departure.